Cato Institute
1000 Massachusetts Ave, NW
Washington, DC 20001-5403
Phone (202) 842 0200
Fax (202) 842 3490
 Contact Us
Support Cato

May 20, 1986
Policy Analysis no. 72

Compassion vs Control: FDA Investigational-Drug Regulation

by Dale H. Gieringer

Dale H. Gieringer is a writer and policy analyst affiliated with the Decisions and Ethics Center of Stanford University.

Published on May 20, 1986

PRINT PAGE
CITE THIS
  Sans Serif
  Serif

Share with your friends:

"The basic problem is, I don't have as much control over what I can do to get well as I want."

--AIDS patient[1]

Dale H. Gieringer is a writer and policy analyst affiliated with the Decisions and Ethics Center of Stanford University.

"I think the FDA should recognize its responsibility for the denial of lifesaving technology."

--Robert Jarvik, developer of the artificial heart[2]

View this Policy Analysis in HTML

Share with your friends:  

© 2009 The Cato Institute
Please send comments to webmaster